Optic Nerve Perfusion Following Treatment with Latanoprost Versus Brimionidin Tartrate

NCT06730516 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

56

Enrollment

OTHER_GOV

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: Latanoprost (Xalatan)
DRUG: Brimonidine 0.2 %

Sponsor

Zagazig University